These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 29358328)

  • 1. A human xenobiotic nuclear receptor contributes to nonresponsiveness of
    Bhagyaraj E; Tiwari D; Ahuja N; Nanduri R; Saini A; Kalra R; Kumar S; Janmeja AK; Gupta P
    J Biol Chem; 2018 Mar; 293(10):3747-3757. PubMed ID: 29358328
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro and in vivo activity of biapenem against drug-susceptible and rifampicin-resistant Mycobacterium tuberculosis.
    Kaushik A; Ammerman NC; Tasneen R; Story-Roller E; Dooley KE; Dorman SE; Nuermberger EL; Lamichhane G
    J Antimicrob Chemother; 2017 Aug; 72(8):2320-2325. PubMed ID: 28575382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ion Channel Blockers as Antimicrobial Agents, Efflux Inhibitors, and Enhancers of Macrophage Killing Activity against Drug Resistant Mycobacterium tuberculosis.
    Machado D; Pires D; Perdigão J; Couto I; Portugal I; Martins M; Amaral L; Anes E; Viveiros M
    PLoS One; 2016; 11(2):e0149326. PubMed ID: 26919135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of ABCG2 efflux pumps renders the Mycobacterium tuberculosis hiding in mesenchymal stem cells responsive to antibiotic treatment.
    Kaur S; Angrish N; Gupta K; Tyagi AK; Khare G
    Infect Genet Evol; 2021 Jan; 87():104662. PubMed ID: 33278633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Mycobacterium tuberculosis Enhancement of Macrophage P-Glycoprotein Expression and Activity on Intracellular Survival During Antituberculosis Drug Treatment.
    Wu Q; Hossfeld A; Gerberick A; Saljoughian N; Tiwari C; Mehra S; Ganesan LP; Wozniak DJ; Rajaram MVS
    J Infect Dis; 2019 Nov; 220(12):1989-1998. PubMed ID: 31412123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rifampicin-induced transcriptome response in rifampicin-resistant Mycobacterium tuberculosis.
    de Knegt GJ; Bruning O; ten Kate MT; de Jong M; van Belkum A; Endtz HP; Breit TM; Bakker-Woudenberg IA; de Steenwinkel JE
    Tuberculosis (Edinb); 2013 Jan; 93(1):96-101. PubMed ID: 23182912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug sensitivity in Mycobacterium tuberculosis versus its viability, cytotoxicity, genotype, and the course of the process in patients with pulmonary tuberculosis].
    Manicheva OA; Lasunskaia EB; Zhuravlev VIu; Otten TF; Barnaulov AO; Mokrousov IV; Pavlova MV; Vishnevskiĭ BI; Narvskaia OV
    Probl Tuberk Bolezn Legk; 2008; (12):18-22. PubMed ID: 19230183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of ketoconazole against Mycobacterium tuberculosis in vitro and in the mouse model.
    Byrne ST; Denkin SM; Gu P; Nuermberger E; Zhang Y
    J Med Microbiol; 2007 Aug; 56(Pt 8):1047-1051. PubMed ID: 17644711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intramacrophage Mycobacterium tuberculosis efflux pump gene regulation after rifampicin and verapamil exposure.
    Canezin PH; Caleffi-Ferracioli KR; Scodro RBL; Siqueira VLD; Pavan FR; Barros ILE; Cardoso RF
    J Antimicrob Chemother; 2018 Jul; 73(7):1770-1776. PubMed ID: 29579201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xenobiotic Nuclear Receptors Pregnane X Receptor and Constitutive Androstane Receptor Regulate Antiretroviral Drug Efflux Transporters at the Blood-Testis Barrier.
    Whyte-Allman SK; Hoque MT; Jenabian MA; Routy JP; Bendayan R
    J Pharmacol Exp Ther; 2017 Dec; 363(3):324-335. PubMed ID: 28970358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Berberine as an Adjunct to TB Treatment.
    Ozturk M; Chia JE; Hazra R; Saqib M; Maine RA; Guler R; Suzuki H; Mishra BB; Brombacher F; Parihar SP
    Front Immunol; 2021; 12():656419. PubMed ID: 34745081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrepancy in the genotypic versus phenotypic testing for resistance to rifampicin in Mycobacterium tuberculosis. A case report.
    Rapún Mas L; Angulo López I; Cecilio Irazola Á; Betrán Escartín AI
    Enferm Infecc Microbiol Clin (Engl Ed); 2019 Mar; 37(3):212-213. PubMed ID: 29773408
    [No Abstract]   [Full Text] [Related]  

  • 13. RNA expression analysis of efflux pump genes in clinical isolates of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in South Korea.
    Oh TS; Kim YJ; Kang HY; Kim CK; Cho SY; Lee HJ
    Infect Genet Evol; 2017 Apr; 49():111-115. PubMed ID: 28062386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of rifapentine and its metabolite 25-O-desacetylrifapentine compared with rifampicin and rifabutin against Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis and M. bovis BCG.
    Rastogi N; Goh KS; Berchel M; Bryskier A
    J Antimicrob Chemother; 2000 Oct; 46(4):565-70. PubMed ID: 11020253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SILA-421 activity in vitro against rifampicin-susceptible and rifampicin-resistant Mycobacterium tuberculosis, and in vivo in a murine tuberculosis model.
    de Knegt GJ; Bakker-Woudenberg IA; van Soolingen D; Aarnoutse R; Boeree MJ; de Steenwinkel JE
    Int J Antimicrob Agents; 2015 Jul; 46(1):66-72. PubMed ID: 25951996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of FASTPlaqueTB-RIF for determination of rifampicin resistance in Mycobacterium tuberculosis complex isolates.
    Kisa O; Albay A; Bedir O; Baylan O; Doganci L
    Int J Tuberc Lung Dis; 2003 Mar; 7(3):284-8. PubMed ID: 12661845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of Xpert MTB/RIF for detection of Mycobacterium tuberculosis and rifampicin resistance in pus aspirates.
    Set R; Bankar S; Sharma D; Shah D; Shastri J
    Indian J Tuberc; 2019 Oct; 66(4):433-436. PubMed ID: 31813428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro combinatory activity of piperine and anti-tuberculosis drugs in Mycobacterium tuberculosis.
    Hegeto LA; Caleffi-Ferracioli KR; Nakamura-Vasconcelos SS; Almeida AL; Baldin VP; Nakamura CV; Siqueira VLD; Scodro RBL; Cardoso RF
    Tuberculosis (Edinb); 2018 Jul; 111():35-40. PubMed ID: 30029912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of rpoB gene mutations in rifampicin resistant Mycobacterium tuberculosis strains isolated from pulmonary tuberculosis patients at 5 Mexican public hospitals.
    Alvarado-Esquivel C; Rossau R; Martínez-García S; Cisneros-Martínez JA; Mijs W; Nevárez-Nájera A; Fierro-Campa R; Mercado-Suárez MF; Hernández-Campos S; Chacón-Arciniega R; Vázquez J; Saucedo-Martínez G; Ruiz-Astorga R
    Rev Invest Clin; 2001; 53(6):526-30. PubMed ID: 11921525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.